Hepatocellular Carcinoma in Africa: Challenges and Opportunities
- PMID: 35814750
- PMCID: PMC9263092
- DOI: 10.3389/fmed.2022.899420
Hepatocellular Carcinoma in Africa: Challenges and Opportunities
Keywords: Africa; cancer; epidemiology; hepatitis B; hepatitis C virus; hepatocellular carcinoma (HCC).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?World J Gastroenterol. 2021 Sep 28;27(36):6025-6038. doi: 10.3748/wjg.v27.i36.6025. World J Gastroenterol. 2021. PMID: 34629817 Free PMC article. Review.
-
Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance - implications for sub-Saharan Africa.S Afr Med J. 2018 Aug 8;108(8b):35-40. doi: 10.7196/SAMJ.2018.v108i8b.13499. S Afr Med J. 2018. PMID: 30182911 Review.
-
Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.Pathol Biol (Paris). 2010 Aug;58(4):273-7. doi: 10.1016/j.patbio.2010.01.005. Epub 2010 Apr 7. Pathol Biol (Paris). 2010. PMID: 20378277
-
Epidemiology of Liver Cancer in Africa: Current and Future Trends.Semin Liver Dis. 2020 May;40(2):111-123. doi: 10.1055/s-0039-3399566. Epub 2019 Nov 14. Semin Liver Dis. 2020. PMID: 31726474 Review.
-
Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):570-2. doi: 10.1016/s0035-9203(97)90029-8. Trans R Soc Trop Med Hyg. 1997. PMID: 9463670
Cited by
-
Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma.Adv Virol. 2025 Mar 24;2025:9927410. doi: 10.1155/av/9927410. eCollection 2025. Adv Virol. 2025. PMID: 40165825 Free PMC article. Review.
-
Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee.J Immunother Cancer. 2025 Jun 22;13(6):e011258. doi: 10.1136/jitc-2024-011258. J Immunother Cancer. 2025. PMID: 40550565 Free PMC article. Review.
-
Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do.Liver Res. 2024 Jun 1;8(2):83-90. doi: 10.1016/j.livres.2024.05.004. eCollection 2024 Jun. Liver Res. 2024. PMID: 39959873 Free PMC article. Review.
-
Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance.Hepatoma Res. 2022;8:39. doi: 10.20517/2394-5079.2022.32. Epub 2022 Oct 14. Hepatoma Res. 2022. PMID: 36277115 Free PMC article.
-
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1821. doi: 10.1002/cnr2.1821. Epub 2023 Jun 21. Cancer Rep (Hoboken). 2023. PMID: 37344125 Free PMC article. Review.
References
-
- London WT, Petrick JL, McGlynn KA. Liver cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld DE. editors. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; (2018). p. 635–60.
-
- Mak D, Kramvis A. Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa. Hepatoma Res. (2021) 7:39. Available online at: https://hrjournal.net/article/view/4046 - PubMed
LinkOut - more resources
Full Text Sources